Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366367065> ?p ?o ?g. }
- W4366367065 endingPage "1059" @default.
- W4366367065 startingPage "1047" @default.
- W4366367065 abstract "How does an altered maternal hormonal environment, such as that seen during superovulation with gonadotropins in ART, impact human uterine immune cell distribution and function during the window of implantation?Hormonal stimulation with gonadotropins alters abundance of maternal immune cells including uterine natural killer (uNK) cells and reduces uNK cell ability to promote extravillous trophoblast (EVT) invasion.An altered maternal hormonal environment, seen following ART, can lead to increased risk for adverse perinatal outcomes associated with disordered placentation. Maternal immune cells play an essential role in invasion of EVTs, a process required for proper establishment of the placenta, and adverse perinatal outcomes have been associated with altered immune cell populations. How ART impacts maternal immune cells and whether this can in turn affect implantation and placentation in humans remain unknown.A prospective cohort study was carried out between 2018 and 2021 on 51 subjects: 20 from natural cycles 8 days after LH surge; and 31 from stimulated IVF cycles 7 days after egg retrieval.Endometrial biopsies and peripheral blood samples were collected during the window of implantation in subjects with regular menstrual cycles or undergoing superovulation. Serum estradiol and progesterone levels were measured by chemiluminescent competitive immunoassay. Immune cell populations in blood and endometrium were analyzed using flow cytometry. uNK cells were purified using fluorescence-activated cell sorting and were subjected to RNA sequencing (RNA-seq). Functional changes in uNK cells due to hormonal stimulation were evaluated using the implantation-on-a-chip (IOC) device, a novel bioengineered platform using human primary cells that mimics early processes that occur during pregnancy in a physiologically relevant manner. Unpaired t-tests, one-way ANOVA, and pairwise multiple comparison tests were used to statistically evaluate differences.Baseline characteristics were comparable for both groups. As expected, serum estradiol levels on the day of biopsy were significantly higher in stimulated (superovulated) patients (P = 0.0005). In the setting of superovulation, we found an endometrium-specific reduction in the density of bulk CD56+ uNK cells (P < 0.05), as well as in the uNK3 subpopulation (P = 0.025) specifically (CD103+ NK cells). In stimulated samples, we also found that the proportion of endometrial B cells was increased (P < 0.0001). Our findings were specific to the endometrium and not seen in peripheral blood. On the IOC device, uNK cells from naturally cycling secretory endometrium promote EVT invasion (P = 0.03). However, uNK cells from hormonally stimulated endometrium were unable to significantly promote EVT invasion, as measured by area of invasion, depth of invasion, and number of invaded EVTs by area. Bulk RNA-seq of sorted uNK cells from stimulated and unstimulated endometrium revealed changes in signaling pathways associated with immune cell trafficking/movement and inflammation.Patient numbers utilized for the study were low but were enough to identify significant overall population differences in select immune cell types. With additional power and deeper immune phenotyping, we may detect additional differences in immune cell composition of blood and endometrium in the setting of hormonal stimulation. Flow cytometry was performed on targeted immune cell populations that have shown involvement in early pregnancy. A more unbiased approach might identify changes in novel maternal immune cells not investigated in this study. We performed RNA-seq only on uNK cells, which demonstrated differences in gene expression. Ovarian stimulation may also impact gene expression and function of other subsets of immune cells, as well as other cell types within the endometrium. Finally, the IOC device, while a major improvement over existing in vitro methods to study early pregnancy, does not include all possible maternal cells present during early pregnancy, which could impact functional effects seen. Immune cells other than uNK cells may impact invasion of EVTs in vitro and in vivo, though these remain to be tested.These findings demonstrate that hormonal stimulation affects the distribution of uNK cells during the implantation window and reduces the proinvasive effects of uNK cells during early pregnancy. Our results provide a potential mechanism by which fresh IVF cycles may increase risk of disorders of placentation, previously linked to adverse perinatal outcomes.Research reported in this publication was supported by the University of Pennsylvania University Research Funding (to M.M.), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD068157 to M.M., S.S., and S.M.), National Center for Advancing Translational Sciences of the National Institutes of Health (TL1TR001880 to J.K.), the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania, the Children's Hospital of Philadelphia Research Institute (to S.M.G.), and the National Institute of Allergy and Infectious Diseases (K08AI151265 to S.M.G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All authors declare no conflict of interest.N/A." @default.
- W4366367065 created "2023-04-21" @default.
- W4366367065 creator A5015891219 @default.
- W4366367065 creator A5017794876 @default.
- W4366367065 creator A5051362726 @default.
- W4366367065 creator A5058725999 @default.
- W4366367065 creator A5066763006 @default.
- W4366367065 creator A5084515555 @default.
- W4366367065 creator A5086799519 @default.
- W4366367065 creator A5089581817 @default.
- W4366367065 date "2023-04-19" @default.
- W4366367065 modified "2023-10-18" @default.
- W4366367065 title "Hormonal stimulation reduces numbers and impairs function of human uterine natural killer cells during implantation" @default.
- W4366367065 cites W134318325 @default.
- W4366367065 cites W1539789596 @default.
- W4366367065 cites W1802391174 @default.
- W4366367065 cites W1918962518 @default.
- W4366367065 cites W1987267883 @default.
- W4366367065 cites W2003080932 @default.
- W4366367065 cites W2007150017 @default.
- W4366367065 cites W2009750404 @default.
- W4366367065 cites W2011586670 @default.
- W4366367065 cites W2012463854 @default.
- W4366367065 cites W2015603949 @default.
- W4366367065 cites W2020621448 @default.
- W4366367065 cites W2024510213 @default.
- W4366367065 cites W2034781980 @default.
- W4366367065 cites W2036015212 @default.
- W4366367065 cites W2046992075 @default.
- W4366367065 cites W2047026162 @default.
- W4366367065 cites W2048226809 @default.
- W4366367065 cites W2060268163 @default.
- W4366367065 cites W2061459613 @default.
- W4366367065 cites W2063108919 @default.
- W4366367065 cites W2097174302 @default.
- W4366367065 cites W2105101447 @default.
- W4366367065 cites W2109896183 @default.
- W4366367065 cites W2110160605 @default.
- W4366367065 cites W2112484452 @default.
- W4366367065 cites W2139843241 @default.
- W4366367065 cites W2140535499 @default.
- W4366367065 cites W2143498816 @default.
- W4366367065 cites W2144473676 @default.
- W4366367065 cites W2148246556 @default.
- W4366367065 cites W2151861846 @default.
- W4366367065 cites W2152284742 @default.
- W4366367065 cites W2161827983 @default.
- W4366367065 cites W2163245985 @default.
- W4366367065 cites W2166223726 @default.
- W4366367065 cites W2167950650 @default.
- W4366367065 cites W2201213085 @default.
- W4366367065 cites W2222113668 @default.
- W4366367065 cites W2323654318 @default.
- W4366367065 cites W2405538125 @default.
- W4366367065 cites W2533442190 @default.
- W4366367065 cites W2594125052 @default.
- W4366367065 cites W2608055428 @default.
- W4366367065 cites W2693237708 @default.
- W4366367065 cites W2730029087 @default.
- W4366367065 cites W2733548904 @default.
- W4366367065 cites W2765587071 @default.
- W4366367065 cites W2775921812 @default.
- W4366367065 cites W2793061596 @default.
- W4366367065 cites W2804465763 @default.
- W4366367065 cites W2810656455 @default.
- W4366367065 cites W2898759023 @default.
- W4366367065 cites W2900144939 @default.
- W4366367065 cites W2901367000 @default.
- W4366367065 cites W2948541339 @default.
- W4366367065 cites W2995215844 @default.
- W4366367065 cites W3029161508 @default.
- W4366367065 cites W3038046135 @default.
- W4366367065 cites W3043873905 @default.
- W4366367065 cites W3134025135 @default.
- W4366367065 cites W3176951690 @default.
- W4366367065 cites W4098901 @default.
- W4366367065 cites W4221000640 @default.
- W4366367065 doi "https://doi.org/10.1093/humrep/dead069" @default.
- W4366367065 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37075311" @default.
- W4366367065 hasPublicationYear "2023" @default.
- W4366367065 type Work @default.
- W4366367065 citedByCount "1" @default.
- W4366367065 countsByYear W43663670652023 @default.
- W4366367065 crossrefType "journal-article" @default.
- W4366367065 hasAuthorship W4366367065A5015891219 @default.
- W4366367065 hasAuthorship W4366367065A5017794876 @default.
- W4366367065 hasAuthorship W4366367065A5051362726 @default.
- W4366367065 hasAuthorship W4366367065A5058725999 @default.
- W4366367065 hasAuthorship W4366367065A5066763006 @default.
- W4366367065 hasAuthorship W4366367065A5084515555 @default.
- W4366367065 hasAuthorship W4366367065A5086799519 @default.
- W4366367065 hasAuthorship W4366367065A5089581817 @default.
- W4366367065 hasConcept C126322002 @default.
- W4366367065 hasConcept C134018914 @default.
- W4366367065 hasConcept C16685009 @default.
- W4366367065 hasConcept C172680121 @default.
- W4366367065 hasConcept C203014093 @default.
- W4366367065 hasConcept C2776953305 @default.